ANALYSIS (THB mn) 1Q 2020 1Q 2019 % YoY 4Q 2019 % QoQ Operating revenues 1,486.6 1,347.6 10.3% 2,205.3 (32.6%) Other revenues 505.8 114.3 343% 1,903.8 (73.4%) Total Revenue 1,992.4 1,461.9 36.3% 4,109.1
Summary Significant Event Operating Highlights in Q2/2024 Q2/23 Q2/24 Change +/(-) 1H/23 1H/24 Change +/(-) (THB million) %YoY %YoY Operating Revenue 299 376 26% 563 716 27% Gross Profit 192 250 30% 361 476
shareholders. (Translation) 6 7. Source of Fund: Cash flows from the Company’s operating activities 8. Opinions of the Board of Directors on Agreement for Execution of the Transaction The Board of Directors
having the voting rights, excluding the votes of interested shareholders. 7. Source of Fund: Cash flows from the Company’s operating activities 8. Opinions of the Board of Directors on Agreement for
votes of interested shareholders. 7. Source of Fund: Cash flows from the Company’s operating activities 8. Opinions of the Board of Directors on Agreement for Execution of the Transaction The Board of
-1- AIT (VP-SEC) 022E/2022 August 11, 2022 Subject: Management's Discussion and Analysis of Operating Results for Q2-2022 To: The President of the Stock Exchange of Thailand Summary of Operations Q1
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
. Procuring of loan policy 12. Return distribution policy and restrictions 13. Financial status and operating results of REIT 14. Future investment policy 15. Other relevant information Part 3: Information on
utilized or have not reached the optimal level yet. Therefore, cost per unit was higher at this point, which might continue to impact the Company’s operating performance in the short term, or for the next 2